Costs analysis of integrating group interpersonal therapy into HIV care services in Senegal
- PMID: 39825458
- PMCID: PMC11740413
- DOI: 10.1186/s13033-024-00654-6
Costs analysis of integrating group interpersonal therapy into HIV care services in Senegal
Abstract
Introduction: Group Interpersonal Therapy (IPT), an evidence-based treatment of depression recommended by the WHO mhGAP Intervention Guide, was implemented through a task-shifting approach in Senegal, as a treatment for depressed people living with HIV (PLWH). Since a description of the resources used and the implementation costs incurred is necessary to inform policymakers better, this study aimed to estimate the costs associated with its implementation.
Methods: Intervention costs were analyzed using an "ingredients-based costing approach" from the provider's perspective. We identified and described the start-up and implementation costs for the initial phase and a projection over 5 years (implementation at capacity). We estimated total annual costs and cost per beneficiary. We conducted a scenario analysis to highlight some cost uncertainties and their impacts.
Results: The total annual costs were estimated at $4064 for the initial phase and $8161 for the implementation at capacity. The training was the main cost driver representing approximately 60% of the total annual costs. The cost per beneficiary receiving group IPT was estimated at $65 for the implementation at capacity. The scenario analysis also illustrated the importance of parameters like the screening strategy, training activities, and allocation to cover transport costs mobilized by participants.
Conclusion: This cost analysis highlighted the costs and cost allocations required to implement group IPT in Senegal to treat depression in PLWH. This preliminary work should enable policymakers to identify the optimal resources to be mobilized to implement and ensure the sustainability of this therapy in HIV at a country-level program.
Keywords: Cost analyses; Depression; Group interpersonal therapy; HIV; Sub-Saharan Africa.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The research was conducted in accordance with the Helsinki Declaration. Ethical approval was obtained from Senegal ethics committee: Conseil National d’Éthique de la Recherche en Santé (CNERS) (approval number: SEN22/49). This paper only comprises non-identifiable, aggregated services data. Consent for publication: Not applicable. This paper only comprises non-identifiable, aggregated services data. Competing interests: The authors declare no competing interests.
Figures
References
-
- World Health Organization. World mental health report—transforming mental health for all. World Health Organization; 2022. p. 296.
-
- Akena D, Stein DJ, Joska J. Does screening HIV-positive individuals in Uganda for major depressive disorder improve case detection rates and antidepressant prescription? AIDS Behav. 2013;17(8):2802–7. - PubMed
-
- Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016;387(10028):1672–85. - PubMed
-
- Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet. 2007;370(9590):878–89. - PubMed
-
- Araya R, Flynn T, Rojas G, Fritsch R, Simon G. Cost-effectiveness of a primary care treatment program for depression in low-income women in Santiago. Chile AJP. 2006;163(8):1379–87. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
